Summary
Intravenous administration of C. parvum following SC immunization with a tumor allograft markedly impaired the generation and expression of primary cell-mediated cytotoxicity to the immunizing alloantigens. For the inhibition to become manifest, a minimum of 4 days of in vivo exposure to C. parvum was necessary, and the effect was seen only when C. parvum was injected during the developing immune response; injection prior to or simultaneously with alloimmunization resulted in no impairment. The inhibition of cell-mediated cytotoxicity was selective. While spleen cell populations exhibited decreased cytotoxic activity, lymphoid cell populations from lymph nodes and blood were unaffected. The inhibitory effect was restricted to the cellular component of the immune response. Complement-dependent cytotoxic antibodies developed normally and their titer was comparable to that of control alloimmunized mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asherson, G. L., Alwood, G. G.: Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. I. Description of the phenomenon. Clin. Exp. Immunol. 9, 249 (1971)
Bach, F. H., Bach, M., Sondel, P. M.: Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature 259, 273 (1976)
Bennett, J. A., Mitchell, M. S.: Intravenous Bacillus Calmette-Guérin (BCG) induces splenic suppressor cells that inhibit in vitro immunization. Proc. Am. Ass. Cancer Res. 19, 22 (1978)
Berd, D. A., Mitchell, M. S.: Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice. Cancer Res. 36, 4119 (1976)
Brunner, K. T., Engers, H. D., Cerottini, J. C.: The 51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In: In vitro methods in cell-mediated and tumor immunity. Bloom, B. R., David, J. R. (eds.), p. 423. New York: Academic Press 1976
Cantor, H., Boyse, E. A.: Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J. Exp. Med. 141, 1390 (1975)
Frost, P., Lance, E. M.: The relationship of lymphocyte trapping to the mode of action of adjuvants. In: Immunopotentiation (Ciba Foundation Symposium no. 18), p. 29. New York: Associated Scientific Publishers 1973
Gray, G. D., Perper, R. J., Mickelson, M. M., Crim, J. A., Zukowski, C. F.: The immunosuppressive activity ara-cytidine (Cytarabine). III. Effects on canine renal allograft rejection and hemagglutinin formation. Transplantation 7, 183 (1969)
Halpern, B. N., Prevot, A. R., Biozzi, G., Stiffel, C., Mouton, D., Morard, J. C., Bouthillier, Y., Decreusefond, C.: Stimulation de l'activité phagocyteure du système réticuloendothélial provoqués par Corynebacterium parvum. J. Reticuloendothel. Soc. 1, 77 (1964)
Heppner, G. H., Calabresi, P.: Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors. J. Natl. Cancer Inst. 48, 1161 (1972)
Limpel, G. R., Henney, C. S.: BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. J. Immunol. 120, 563 (1978)
Murahata, R. I., Zighelboim, J.: Inhibition of memory cell-mediated cytotoxic response by systemic administration of Corynebacterium parvum. Cell. Immunol. (in press, 1979).
Poulter, L. W., Turk, J. L.: Proportional increase in the macrophage carrying lymphocytes in peripheral lymphoid tissue following treatment with cyclophosphamide. Nature New Biol. 238, 17 (1972)
Sadler, T. E., Castro, J. E.: Lack of immunological and antitumor effects of orally administered Corynebacterium parvum in mice. Br. J. Cancer 31, 359 (1975)
Scott, M. T.: Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte, and GVH reactivity. Cell. Immunol. 5, 459 (1972a)
Scott, M. T.: Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction. Cell. Immunol. 5, 469 (1972b)
Scott, M. T.: Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell. Immunol. 13, 251 (1974)
Wagner, H., Feldmann, M., Boyle, W., Schrader, J. W.: Cell-mediated immune responses in vitro. III. Requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens. J. Exp. Med. 136, 331 (1972)
Warr, G. W., Sljivic, V. C.: Enhancement and depression of the antibody response in mice caused by Corynebacterium parvum. Clin. Exp. Immunol. 17, 519 (1974)
Woodruff, M. F. A., Haffar, A., Dunbar, N., Whitehead, V. L.: Effect of C. parvum on immunization with irradiated tumor cells. Br. J. Cancer 33, 491 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murahata, R.I., Zighelboim, J. Inhibition of cell-mediated cytotoxicity to tumor alloantigens by systemic administration of Corynebacterium parvum . Cancer Immunol Immunother 6, 101–106 (1979). https://doi.org/10.1007/BF00200138
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200138